BDO assisted BVI Medical with the financial and tax due diligence on Arcadophta
24 December 2019
BVI, one of the fastest growing diversified companies in ophthalmology has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. Growth of the Arcad products will be accelerated through BVI's broad-reaching commercial infrastructure established with the Vitreq line of vitreoretinal surgical products.
Arcad has developed a proprietary process of purification and fractionation that delivers high quality products for use by surgeons. Additionally, the company has developed certain single-use and easy to administer delivery systems for products. Arcad brings over 25 years of expertise in the ophthalmic space and a strong history in close collaboration with surgeons worldwide.
BDO Transaction Services team, led by Alexander Veithen (BDO Belgium) and Sacha Boksenbaum (BDO France), assisted BVI in this transaction by conducting the financial and tax buy-side due diligence work.